164 related articles for article (PubMed ID: 26058670)
1. A multi-Gaussian model for apparent diffusion coefficient histogram analysis of Wilms' tumour subtype and response to chemotherapy.
Hales PW; Olsen ØE; Sebire NJ; Pritchard-Jones K; Clark CA
NMR Biomed; 2015 Aug; 28(8):948-57. PubMed ID: 26058670
[TBL] [Abstract][Full Text] [Related]
2. An alternative approach to contrast-enhanced imaging: diffusion-weighted imaging and T
Rogers HJ; Verhagen MV; Shelmerdine SC; Clark CA; Hales PW
Eur Radiol; 2019 Aug; 29(8):4141-4149. PubMed ID: 30560365
[TBL] [Abstract][Full Text] [Related]
3. Whole-tumor apparent diffusion coefficient measurements in nephroblastoma: Can it identify blastemal predominance?
Littooij AS; Sebire NJ; Olsen ØE
J Magn Reson Imaging; 2017 May; 45(5):1316-1324. PubMed ID: 27726252
[TBL] [Abstract][Full Text] [Related]
4. Intra- and interobserver variability of whole-tumour apparent diffusion coefficient measurements in nephroblastoma: a pilot study.
Littooij AS; Humphries PD; Olsen ØE
Pediatr Radiol; 2015 Oct; 45(11):1651-60. PubMed ID: 25951925
[TBL] [Abstract][Full Text] [Related]
5. Comparison of models of diffusion in Wilms' tumours and normal contralateral renal tissue.
Rogers HJ; Verhagen MV; Clark CA; Hales PW
MAGMA; 2021 Apr; 34(2):261-271. PubMed ID: 32617696
[TBL] [Abstract][Full Text] [Related]
6. Apparent diffusion coefficient as it relates to histopathology findings in post-chemotherapy nephroblastoma: a feasibility study.
Littooij AS; Nikkels PG; Hulsbergen-van de Kaa CA; van de Ven CP; van den Heuvel-Eibrink MM; Olsen ØE
Pediatr Radiol; 2017 Nov; 47(12):1608-1614. PubMed ID: 28669064
[TBL] [Abstract][Full Text] [Related]
7. Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG).
van den Heuvel-Eibrink MM; van Tinteren H; Bergeron C; Coulomb-L'Hermine A; de Camargo B; Leuschner I; Sandstedt B; Acha T; Godzinski J; Oldenburger F; Gooskens SL; de Kraker J; Vujanic GM; Pritchard-Jones K; Graf N
Eur J Cancer; 2015 Mar; 51(4):498-506. PubMed ID: 25592561
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of histopathological response to preoperative chemotherapy in unilateral Wilms' tumor: An analysis of 899 patients treated on the SIOP WT 2001 protocol in the UK-CCLG and GPOH studies.
Vujanić GM; D'Hooghe E; Graf N; Vokuhl C; Al-Saadi R; Chowdhury T; Pritchard-Jones K; Furtwängler R
Int J Cancer; 2021 Sep; 149(6):1332-1340. PubMed ID: 34109628
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic utility of Wilms' tumour-1 protein (WT-1) immunostaining in paediatric renal tumours.
Goyal S; Mishra K; Sarkar U; Sharma S; Kumari A
Indian J Med Res; 2016 May; 143(Supplement):S59-S67. PubMed ID: 27748279
[TBL] [Abstract][Full Text] [Related]
10. Differentiation between malignant and benign thyroid nodules and stratification of papillary thyroid cancer with aggressive histological features: Whole-lesion diffusion-weighted imaging histogram analysis.
Hao Y; Pan C; Chen W; Li T; Zhu W; Qi J
J Magn Reson Imaging; 2016 Dec; 44(6):1546-1555. PubMed ID: 27093648
[TBL] [Abstract][Full Text] [Related]
11. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
[TBL] [Abstract][Full Text] [Related]
12. Arterial spin labelling and diffusion-weighted imaging in paediatric brain tumours.
Hales PW; d'Arco F; Cooper J; Pfeuffer J; Hargrave D; Mankad K; Clark C
Neuroimage Clin; 2019; 22():101696. PubMed ID: 30735859
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of histologic subtypes in localized non-anaplastic nephroblastoma treated according to the trial and study SIOP-9/GPOH.
Weirich A; Leuschner I; Harms D; Vujanic GM; Tröger J; Abel U; Graf N; Schmidt D; Ludwig R; Voûte PA
Ann Oncol; 2001 Mar; 12(3):311-9. PubMed ID: 11332141
[TBL] [Abstract][Full Text] [Related]
14. Histogram analysis of apparent diffusion coefficient map of diffusion-weighted MRI in endometrial cancer: a preliminary correlation study with histological grade.
Woo S; Cho JY; Kim SY; Kim SH
Acta Radiol; 2014 Dec; 55(10):1270-7. PubMed ID: 24316663
[TBL] [Abstract][Full Text] [Related]
15. Quantitative evaluation of diffusion-kurtosis imaging for grading endometrial carcinoma: a comparative study with diffusion-weighted imaging.
Chen T; Li Y; Lu SS; Zhang YD; Wang XN; Luo CY; Shi HB
Clin Radiol; 2017 Nov; 72(11):995.e11-995.e20. PubMed ID: 28774471
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted imaging: Apparent diffusion coefficient histogram analysis for detecting pathologic complete response to chemoradiotherapy in locally advanced rectal cancer.
Choi MH; Oh SN; Rha SE; Choi JI; Lee SH; Jang HS; Kim JG; Grimm R; Son Y
J Magn Reson Imaging; 2016 Jul; 44(1):212-20. PubMed ID: 26666560
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of effect of preoperative chemotherapy on Wilms' tumor histopathology.
Taskinen S; Lohi J; Koskenvuo M; Taskinen M
J Pediatr Surg; 2018 Aug; 53(8):1611-1614. PubMed ID: 29074135
[TBL] [Abstract][Full Text] [Related]
18. Diffusion-weighted MRI in the assessment of nephroblastoma: results of a multi-center trial.
Hötker AM; Lollert A; Mazaheri Y; Müller S; Schenk JP; Mildenberger PC; Akin O; Graf N; Staatz G
Abdom Radiol (NY); 2020 Oct; 45(10):3202-3212. PubMed ID: 32166338
[TBL] [Abstract][Full Text] [Related]
19. The value of diffusion-weighted imaging for monitoring the chemotherapeutic response of osteosarcoma: a comparison between average apparent diffusion coefficient and minimum apparent diffusion coefficient.
Oka K; Yakushiji T; Sato H; Hirai T; Yamashita Y; Mizuta H
Skeletal Radiol; 2010 Feb; 39(2):141-6. PubMed ID: 19924412
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer.
Horvat JV; Bernard-Davila B; Helbich TH; Zhang M; Morris EA; Thakur SB; Ochoa-Albiztegui RE; Leithner D; Marino MA; Baltzer PA; Clauser P; Kapetas P; Bago-Horvath Z; Pinker K
J Magn Reson Imaging; 2019 Sep; 50(3):836-846. PubMed ID: 30811717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
